Silene Biotech

Acquired

Facts

Sectors
Biotech, Life Sciences, Stem Cell, Cryopreservation, Biobanking
Status
Acquired (2019)
Stage
Acquired

Is this your organization? Claim it

Uh-Oh Labs’ COVID home molecular test gains limited FDA approval; 96.1% accuracy, detects 400 viral copies

Uh-Oh Labs, founded by Cameron Ball, developed a molecular COVID-19 rapid home test that is 96.1% accurate with no false positives and a detection limit of 400 viral copies, and has received limited FDA approval. Since its 2018 launch the startup has raised funding including $50,000 from Johns Hopkins, $3 million from angels, $15 million from NIH, and a $500,000 investment from Y Combinator this month.

Curi Bio raises $10M to advance iPSC-based 3D tissue drug-discovery platforms including Mantarray

Seattle-based Curi Bio raised $10 million in Series A financing to advance its human iPSC-based drug discovery platforms, including 3D engineered tissue products like Mantarray and Cytostretcher. The company provides customized assay and screening services for cardiac, musculoskeletal and neuromuscular models and has prior funding including $6M this spring and over $6M in NIH grants.

See all 5 stories, episodes and videos about Silene Biotech.